Literature DB >> 20868405

Atrophic vaginitis.

Catherine S Stika1.   

Abstract

With the loss of estrogen that occurs with menopause, physiologic and structural changes occur within the vulvovaginal mucosa that lead to a condition commonly called atrophic vaginitis. Although mild genital changes occur in most women, 10-47% of postmenopausal women will develop one or more debilitating symptoms that include vulvovaginal dryness, dyspareunia, vulvar itching or pain, recurrent urinary tract infections, as well as abnormal vaginal discharge. Topical estrogen replacement therapies reverse these mucosal changes and are effective treatments for the symptoms of atrophic vaginitis. Vaginal moisturizers and lubricants also provide symptomatic relief for vaginal dryness and dyspareunia, respectively.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20868405     DOI: 10.1111/j.1529-8019.2010.01354.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  19 in total

Review 1.  Assessment of vaginal atrophy: a review.

Authors:  M A Weber; J Limpens; J P W R Roovers
Journal:  Int Urogynecol J       Date:  2014-07-22       Impact factor: 2.894

2.  Clinical trial shows lasting function of a new moisturizing cream against vaginal dryness.

Authors:  Hans-Heinrich Henneicke-von Zepelin; Ragna Williams; Wiebke Havemeister; Walter Wigger-Alberti; Klaus-Ulrich Nolte
Journal:  Wien Med Wochenschr       Date:  2017-01-13

Review 3.  Anatomy and Physiology of the Urinary Tract: Relation to Host Defense and Microbial Infection.

Authors:  Duane R Hickling; Tung-Tien Sun; Xue-Ru Wu
Journal:  Microbiol Spectr       Date:  2015-08

Review 4.  Missing documentation in breast cancer survivors: genitourinary syndrome of menopause.

Authors:  Elise D Cook; Elena I Iglehart; George Baum; Leslie L Schover; Lonzetta L Newman
Journal:  Menopause       Date:  2017-12       Impact factor: 2.953

Review 5.  A new era of the vaginal microbiome: advances using next-generation sequencing.

Authors:  Jennifer M Fettweis; Myrna G Serrano; Philippe H Girerd; Kimberly K Jefferson; Gregory A Buck
Journal:  Chem Biodivers       Date:  2012-05       Impact factor: 2.408

6.  Effects of PPAR-delta agonist and zinc on vaginal smooth muscle cells collagen and tropoelastin production.

Authors:  Peter Takacs; Yanping Zhang; Keith Candiotti; Sindy Jaramillo; Carlos A Medina
Journal:  Int Urogynecol J       Date:  2012-05-11       Impact factor: 2.894

7.  Red is not a proxy signal for female genitalia in humans.

Authors:  Sarah E Johns; Lucy A Hargrave; Nicholas E Newton-Fisher
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

8.  Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.

Authors:  Joanne Lester; Gaurav Pahouja; Barbara Andersen; Maryam Lustberg
Journal:  J Pers Med       Date:  2015-03-25

Review 9.  Role of Vaginal Microbiota Dysbiosis in Gynecological Diseases and the Potential Interventions.

Authors:  Yiwen Han; Zhaoxia Liu; Tingtao Chen
Journal:  Front Microbiol       Date:  2021-06-18       Impact factor: 5.640

10.  Barriers to effective treatment of vaginal atrophy with local estrogen therapy.

Authors:  Suzanne Reiter
Journal:  Int J Gen Med       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.